StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3054% below fair value
$42.99−0.65 (-1.49%)

Close on Nov 19, 2026Market cap $62.30BP/E 17.4Yield –

Boston Scientific Days Sales Outstanding (DSO, days) by Quarter

Days Sales Outstanding (DSO, days) (days)

Boston Scientific Days Sales Outstanding (DSO, days): 56 days in Q3 2026, up 9.8% from a year earlier. That is the highest of the 19 quarters on record here.

Latest, Q3 2026
56
Period ended Sep 30, 2026
Change on a year earlier
+9.8%
51 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
15
Documents cited below

Where the Q3 2026 figure comes from

“Days Sales Outstanding (DSO) Free Cash Flow* | Sep Jun Mar Dec Sep / 2026 2026 2026 2025 2025: 56 51 52 51 51”

Source: BSX FY2026Q3 Financial & Operational Highlights Presentation ↗

Rolling 5-quarter working capital efficiency metric disclosed in every quarterly FOH presentation (FY2022Q1–FY2026Q3).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDays Sales Outstanding (DSO, days) (days)Year on yearSource
Q3 2026Sep 30, 202656+9.8%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q2 2026Jun 30, 2026510.0%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q1 2026Mar 31, 2026520.0%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q4 2025Dec 31, 202551-1.9%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q3 2025Sep 30, 202551-7.3%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q2 2025Jun 30, 202551-3.8%BSX FY2026Q2 Financial & Operational Highlights Presentation ↗
Q1 2025Mar 31, 202552-3.7%BSX FY2026Q1 Financial & Operational Highlights Presentation ↗
Q4 2024Dec 31, 202452-5.5%BSX FY2025Q4 Financial & Operational Highlights Presentation ↗
Q3 2024Sep 30, 2024550.0%BSX FY2025Q3 Financial & Operational Highlights Presentation ↗
Q2 2024Jun 30, 202453-1.9%BSX FY2025Q2 Financial & Operational Highlights Presentation ↗
Q1 2024Mar 31, 202454-1.8%BSX FY2025Q1 Financial & Operational Highlights Presentation ↗
Q4 2023Dec 31, 202355-1.8%BSX FY2024Q4 Financial & Operational Highlights Presentation ↗
Q3 2023Sep 30, 202355+1.9%BSX FY2024Q3 Financial & Operational Highlights Presentation ↗
Q2 2023Jun 30, 2023540.0%BSX FY2024Q2 Financial & Operational Highlights Presentation ↗
Q1 2023Mar 31, 2023550.0%BSX FY2024Q1 Financial & Operational Highlights Presentation ↗
Q4 2022Dec 31, 202256–BSX FY2023Q4 Financial & Operational Highlights Presentation ↗

Cite this data

StockData. (2026). Boston Scientific Days Sales Outstanding (DSO, days) (days), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/wc-dso

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?